Jyong Biotech Reports Transformative Period of Clinical Validation and Commercialization Attempt: Phase II Data Focuses on Dual Therapeutic Potential of MCS-8 in Oncology and Metabolic Health, Alongside Strategic Market Entry into Asia
- Comprehensive review of recent milestones highlights statistically significant efficacy in prostate cancer prevention, discovery of novel lipid-modulating properties, and the execution of high-value commercial partnerships in South Korea and...
SINEXCEL and Phoenix Contact Sign Global Strategic Partnership Agreement
SHENZHEN, China, May 22, 2025 /PRNewswire/ -- SINEXCEL(300693.SZ) has officially signed a global strategic partnership agreement with Phoenix Contact at the PHIIDF (Phoenix Contact Innovation and Industry Development Forum) in Shenzhen. SINEXCEL and...